and safe use of vitamin D-3 in pharmaceutical and food industries requ
ires imperatively to solve the problem of its stability and its disper
sion within complex matrices such as drugs and foodstuffs. Inclusion c
omplex formation with cyclodextrins seems to be the best solution. At
industrial scale, the final product is a solid form. We investigated U
V/VIS spectrophotometry, infrared spectroscopy, H-1 and C-13 nuclear m
agnetic resonance, mass spectrometry and X-ray diffraction in order to
determine the most appropriate technique for the characterization of
the solid inclusion complex of vitamin D-3 by either beta-cyclodextrin
or gamma-cyclodextrin and we used molecular modeling under GENMOL(R)
to continue to explore the inclusion of vitamin Dg and its most import
ant metabolite in these cyclodextrins.